The loss of heterozygosity in retinoblastoma and p53 suppressor genes as a prognostic indicator for head and neck cancer

Laryngoscope

Volumn 106, Issue 11, 1996, Pages 1378-1381

  Gleich, Lyon L ^a   Li, Ya Qin ^a   Biddinger, Paul W ^a   Gartside, Peter S ^a   Stambrook, Peter J ^a   Pavelic, Zlatko P ^a   Gluckman, Jack L ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; HEAD AND NECK CANCER; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SUPPRESSOR GENE; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; FEMALE; GENES, P53; GENES, RETINOBLASTOMA; HEAD AND NECK NEOPLASMS; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0029854227     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199611000-00013     Document Type: Article

References (21)

1. Field JK, Pavelic ZP, Spandidos DA, et al. The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1993; 119:1118-1122.
2. Sambrook J, Fritsch EF, Maniatas T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
3. Kondoleon S, Vissing H, Luo XY, et al. A hypervariable RFLP on chromosome 17p13 is defined by an arbitrary single copy probe p144-D6 (HGM9 no. D17S34). Nucleic Acids Res. 1987;15:10605.
4. Vissing H, Grosveld F, Solomon E, et al. Progress towards construction of a total restriction fragment map of a human chromosome. Nucleic Acids Res. 1987;15:1363-1375.
5. Nakamura Y, Leppert M, O'Connell P, et al. Variable number of tandem repeat (VNTR) markers for human gene mapping. Science. 1987;235:1616-1622.
6. Wiggs J, Nordenskjold M, Yandell D, et al. Prediction of the risk of hereditary retinoblastoma using DNA polymorphisms within the retinoblastoma gene. N Engl J Med. 1988; 318:151-157.
7. Toguchida J, McGee TL, Paterson JC, et al. Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics. 1993;17:535-543.
8. McGee TL, Cooley GS, Yandell DW, et al. Detection of the Xbal RFLP within the retinoblastoma locus by PCR. Nucleic Acids Res. 1990;18:207.
9. Yandell DW, Dryja TP. Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing. Am J Hum Genet. 1989;45:547-555.
10. Boynton RF, Huang Y, Blount PL, et al. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Res. 1991;51:5766-5769.
11. Lee NK, Ye Y-W, Chen J, et al. p53, Retinoblastoma, and human papillomavirus in squamous cell carcinoma and adjacent normal mucosa of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg. 1993;119:1125-1131.
12. Sato T, Akiyama F, Sakamoto G, et al. Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res. 1991;51:5794-5799.
13. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet. 1993;9:138-141.
14. Harvey M, Vogel H, Lee EY-HP, et al. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res. 1995;55:1146-1151.
15. Li X, Lee NK, Ye Y-W, et al. Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer. J Natl Cancer Inst 1994;86:1524-1529.
16. Fracchiolla NS, Pignataro L, Capaccio P, et al. Multiple genetic lesions in laryngeal squamous cell carcinoma. Cancer. 1995; 75:1292-1301.
17. Scholnick SB, Sun PC, Shaw ME, et al. Frequent loss of heterozygosity for Rb, TP53, and chromosome arm 3p, but not NME1 in squamous cell carcinoma of the supraglottic larynx. Cancer. 1994;73:2472-2480.
18. Yoo, GH, Xu H-J, Brennan JA, et al. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res. 1994;54:4603-4606.
19. Ahomadegbe JC, Barrois M, Fogel S, et al. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases: absence of correlation with clinical outcome - frequent protein overexpression in normal epithelium and in early noninvasive lesions. Oncogene. 1995;10:1217-1227.
20. Ookawa K, Sakamoto M, Hirohashi S, et al. Concordant p53 and DCC alterations and allelic losses in chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma. Int J Cancer. 1993;53:382-387.
21. Peller S, Halevy A, Slutzki S, et al. p53 Mutations in matched primary and metastatic human tumors. Mol Carcinog. 1995; 13:166-172.